Brewer Sports International (BSI), a multi-faceted global sports
advisory firm, and Amarantus BioScience Holdings, Inc.
(OTCQB:AMBS), a biotechnology company focused on the discovery and
development of novel diagnostics and therapeutics related to cell
cycle dysregulation, endoplasmic reticulum stress,
neurodegeneration and apoptosis, will be hosting the 3rd
Alzheimer's-Focused #C4CT Summit powered by MDM Worldwide at the
United Nations today.
The Summit will focus on the current state of concussions and
the potential link between traumatic brain injury (TBI) and
neurodegenerative diseases like Alzheimer's. A diverse working
group of clinicians, medical researchers, policy makers,
international diplomats, athletes, celebrities, and philanthropic
organizations will be assembled to raise awareness, advance
clinical research, and develop public policy in order to address
this major unmet medical need and public health issue.
The Summit will be broadcast live here. There will also be live
Tweets from @BrewerSports, @Amarantusbio, and @MDMWorldwide
throughout the day. All can join the conversation on Twitter by
using the hashtag #C4CT.
#C4CT Concussion Awareness Summit Agenda
Thursday, July 31, 2014 // United Nations // 9:00am -
6:00pm // *All times and panelists/presenters subject to
change
9:00am – 9:20am: Opening Keynote
- The Honorable Chaka Fattah (D-PA), Member of
Congress
9:30am - 10:00am: Welcome
- H.E. Ambassador Jack Brewer, CEO of The Brewer
Group, Inc.
- Gerald Commissiong, President & CEO of
Amarantus BioScience
- Janet Carbary, CFO of One Mind
- H.E. Ambassador Ali'ioaiga Feturi Elisaia,
Permanent Mission of the Independent State of Samoa to the United
Nations
10:00am - 10:40am: Brain Trauma Leading to Alzheimer's
Disease and Chronic Traumatic Encephalopathy: What We Know and What
We Need to Know
- Robert Stern, Ph.D., Professor of Neurology,
Neurosurgery, and Anatomy and Neurobiology, Clinical Core Director
of BU Alzheimer's Disease Center, Boston University School of
Medicine
10:50am - 11:50am: The Current State of Sports
Concussion Panel
Moderator: Robert Cantu, M.A., M.D., F.A.C.S.,
F.A.A.N.S., F.I.C.S., F.A.C.S.M., Clinical Professor of
Neurology and Neurosurgery, Boston University School of Medicine;
Medical Director of National Center for Catastrophic Sport Injury
Research and Sports Legacy Institute (SLI)
- Charles Bernick, M.D., Associate Director,
Cleveland Clinic Lou Ruvo Center for Brain Health
- Allen Brown, M.D., Consultant, Chair, Division
of Brain Rehabilitation, Department of Physical Medicine and
Rehabilitation; Project Director, Traumatic Brain Injury Model
Systems Center, Mayo Clinic in Rochester, MN
- Anthony Choo, Ph.D., Senior Scientist at
PsychoGenics
- Stefan M. Duma, Ph.D., Harry C. Wyatt
Professor and Department Head, Virginia Tech - Wake Forest
University School of Biomedical Engineering and Sciences
- Andrew Maas, M.D., Ph.D., Professor and
Chairman, Department of Neurosurgery, Antwerp University Hospital
and University of Antwerp
- Chris Nowinski, Co-Founder & Executive
Director of Sports Legacy Institute; Co-Director for the Center for
the Study of Traumatic Encephalopathy at Boston University School
of Medicine; Former WWE Wrestler
- Adam Simon, President & CEO of Cerora
12:00pm - 1:00pm: Networking Lunch
1:10pm - 2:15pm: New Insights from Recent Alzheimer's
Research: Implications for TBI and CTE
Moderator: Howard Fillit, M.D., Executive
Director and Chief Science Officer, Alzheimer's Drug Discovery
Foundation
- Donna Cross, Ph.D., Associate Professor of
Radiology; Director, WaNPRC PET Imaging Center; Co-Director CHDD
Small Animal Imaging Core, University of Washington, Department of
Radiology
- Robert Stern, Ph.D., Professor of Neurology,
Neurosurgery, and Anatomy and Neurobiology, Clinical Core Director
of BU Alzheimer's Disease Center, Boston University School of
Medicine
- Bruce Lamb, Ph.D., Staff Scientist Department
of Neurosciences, The Cleveland Clinic Foundation
- Bobby Heagerty, MA, Director of Community
Affairs & Education at OHSU Brain Institute
2:20pm - 3:00pm: Emerging Theories in Alzheimer's
Disease
- Thomas Arendt, M.D., DSc., Managing Director
of the Paul Flechsig Institute of Brain Research, Leipzig
University and Director of the Alzheimer Centre Leipzig
- Dr. Louis Kirby, Board of Advisors, Amarantus
BioScience
3:00pm - 3:45pm: Family Offices Panel
Moderator: J. Michael Moffat, Chief Executive
Officer and Head of Family Office Relations, Cavendish Global;
Founder and Chief Executive Officer of Black Ash Holdings; Director
of USNY Bank; Board of Directors and Board of Trustees of The
Scriven Foundation, The Farmers' Museum, and Bassett Healthcare
Network
- Walter Schmidt, Ph.D., Chief Executive
Officer, Affiris AG
- Frank Mattner, Ph.D., Chief Scientific
Officer, Affiris AG
- Rick Fort, Ph.D., President and CEO, Family
Office Investor, CereScan
- S. Gregory Hipskind, M.D., Ph.D., Chief
Medical Advisor, CereScan
3:50pm - 4:40pm: Public Policies Panel
Moderator: Andrea Kremer, Chief Correspondent
for Player Health and Safety at the NFL Network
- Janet Carbary, CFO of One Mind
- Gerald Commissiong, President & CEO of
Amarantus BioScience
- Susan Connors, President & CEO of Brain
Injury Association of America
- Nicole Fisher, M.P.P., Ph.D. Student, HHR
Strategies, Inc, Forbes Contributor
- The Honorable James C. Greenwood, President
& CEO of the Biotechnology Industry Organization (BIO)
- Scott Liebman, Partner, Loeb & Loeb
LLP
- Jeff Last, Associate Director for Federal
Affairs, Public Policy Office of the Alzheimer's Association
4:45pm - 5:10pm: Ben Utecht Video
Presentation
5:10pm – 5:25pm: Andrea Kremer Exclusive Interview with
Sidney Rice
5:30pm - 6:15pm: Current and Former Professional
Athletes' Personal Stories
Moderator: Andrew Brandt, NFL Business Analyst,
ESPN
- Alecko Eskandarian, Former MLS Player,
Assistant Coach, New York Cosmos
- EJ Henderson, NFL Pro Bowler, Former NFL
Linebacker
- Qiana Martin, International Athlete/Global
Soccer Ambassador
- Clinton Portis, 2X NFL Pro Bowler, Former NFL
Running Back
- Darrell Reid, NFL Super Bowl Champion, Former
NFL Linebacker
- Sidney Rice, NFL Pro Bowler, Super Bowl
Champion
- Ben Utecht, NFL Super Bowl Champion, Recording
Artist, Motivational Speaker, and National Concussion and Brain
Disease Advocate, Recipient of 2014 PLINA Award (Public Leadership
In Neurology Award)
#C4CT MISSION
The Coalition for Concussion Treatment (#C4CT) serves as a
platform to spread awareness about concussions and the severe
effects of Traumatic Brain Injury (TBI). Through a global campaign
uniting people who are passionate about the cause, #C4CT fosters
the critical discussions and partnerships needed to enhance
research, treatment efforts and prevention. The overall goal of the
coalition is to continue building awareness of key scientific and
medical advances in an ongoing effort to identify and develop new
TBI treatment opportunities.
#C4CT CONCUSSION AWARENESS SUMMIT
Thursday, July 31, 2014 United Nations, New York
City Doors open at 8:30 am // Summit starts at 9:00 am
Presented By: Amarantus Bioscience Holdings and Brewer Sports
International Powered By: MDM Worldwide Topics Include:
The Current State of Sports Concussions, TBI and the Potential Link
to Alzheimer's disease, Alzheimer's Research and Potential
Treatments, Funding and Public Policy, Current and Former
Professional Athletes' Personal Stories
More Info on: www.c4ctsummit.com
Share your support for #C4CT on Twitter!
About #C4CT
The Coalition for Concussion Treatment (#C4CT) was founded in
2012 by former NFL player Jack Brewer, CEO of Brewer Sports
International and Gerald Commissiong, President and CEO at
Amarantus BioScience Holdings, Inc. with the goal of bringing
together those who are directly affected by TBI-induced
neurodegenerative diseases with world class researchers,
scientists, and industry leaders who are actively working towards
identifying and developing innovative TBI treatment opportunities.
#C4CT serves as a platform to spread awareness about concussions
and the severe effects of Traumatic Brain Injury (TBI). #C4CT
fosters the critical discussions and partnerships needed to enhance
research, treatment efforts, and prevention through a global
campaign uniting people who are passionate about the
cause.
About Amarantus BioScience Holdings, Inc.
Amarantus BioScience Holdings (AMBS) is a biotechnology company
developing treatments and diagnostics for diseases associated with
neurodegeneration and protein misfolding-related apoptosis. AMBS
has licensed Eltoprazine ("Eltoprazine"), a phase 2b ready small
molecule indicated for Parkinson's Levodopa induced dyskinesia and
Adult ADHD. AMBS has an exclusive worldwide license to the
Lymphocyte Proliferation test ("LymPro Test®") for Alzheimer's
disease and owns the intellectual property rights to a therapeutic
protein known as Mesencephalic-Astrocyte-derived Neurotrophic
Factor ("MANF") and is developing MANF-based products as treatments
for brain disorders. AMBS also owns intellectual property for the
diagnosis of Parkinson's disease ("NuroPro") and the discovery of
neurotrophic factors ("PhenoGuard"). Amarantus operations are
located at Janssen Labs @QB3 in San Francisco, CA. For further
information please visit www.Amarantus.com, or connect with the
Company on Facebook, LinkedIn, Twitter and Google+.
About Brewer Sports International
Founded by international entrepreneur Jack Brewer, five-year
National Football League (NFL) veteran and former three-team
captain, Brewer Sports International (BSI) is a multi-faceted
global sports advisory firm within The Brewer Group Companies with
a focus on the business of sport and wellness for professional
athletes, sports agencies, public and private corporations and
various partners including international organizations, governments
and NGOs. Based in Minneapolis with offices spanning the globe, BSI
offers a unique financial services platform to professional
athletes and sports agencies, as well as high-net-worth individuals
and businesses related to sports. BSI takes pride in enabling its
clients to capitalize on the endless opportunities presented
through sport. For more information, please visit
www.brewersports.com or follow them on Facebook, Twitter and
LinkedIn.
About MDM Worldwide
MDM Worldwide Solutions, Inc. is a digital communications agency
that develops and manages online engagement strategies to connect
companies with their stakeholders. MDM specializes in working with
clients in the technology, healthcare and life sciences spaces.
MDM's vast industry knowledge, proprietary methodology, proven
track record and experienced leadership team enables them to create
and customize targeted digital marketing campaigns to fulfill all
of their clients' objectives. For more information, please visit
mdmworldwide.com or find them
on Facebook, Twitter, Google+ and LinkedIn.
CONTACT: Amarantus Bioscience Holdings, Inc.:
Aimee Boutcher, Director of Investor Relations
408.737.2734 x 101
ir@amarantus.com
Brewer Sports International:
Kristi Hofacker, Director of Interactive Marketing & Media
The Brewer Group, Inc.
kristi.hofacker@thebrewergroup.com
651.247.4460
Amarantus Bioscience (CE) (USOTC:AMBS)
Historical Stock Chart
From Aug 2024 to Sep 2024
Amarantus Bioscience (CE) (USOTC:AMBS)
Historical Stock Chart
From Sep 2023 to Sep 2024